Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Entegris Inc (ENTG) vs Altria Group Inc (MO) Price & Performance

Entegris IncTrade
Altria Group IncTrade

Price performance (Past 24H)

Key statistics

Entegris Inc vs Altria Group Inc — how do they compare? Entegris Inc trades at $165.08 (market cap $25.41B), while Altria Group Inc trades at $71.26 (market cap $119.25B). The key difference: Altria Group Inc is far larger — about 4.7× Entegris Inc's market cap, and Altria Group Inc pays the higher dividend (6.22%). Which is the better fit depends on your goals — on Pluang, investors hold Entegris Inc for 41 Days and Altria Group Inc for 154 Days on average.

ENTGMO
Market Cap
$25.41B$119.25B
Volume
2,160,23211,178,169
Sector
TechnologyConsumer Staples
52-Week High
$184.00$74.92
52-Week Low
$68.80$54.72
Typical Hold Time
41 Days154 Days
Enterprise Value
$28.62B$141.46B
Dividend Yield
0.24%6.22%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Entegris Inc

ENTG trades at $166.32, down 0.34% on the day, with strong technical momentum showing bullish moving averages and key resistance at $168. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results expected October 29. Revenue remains stable at $3.2B (2025) with improving net margins from 5.12% (2023) to 7.37% (2025), though valuation ratios appear elevated with P/E at 83.16.

Wall Street maintains strong bullish sentiment with 70% buy ratings and $182.43 consensus price target, representing 9.7% upside. Key risks include high debt levels ($3.98B) and semiconductor industry cyclicality. The upcoming Q3 earnings and November Investor Day will be critical catalysts for near-term direction.

Altria Group Inc

Altria Group (MO) trades at $69.39, up 1.22% today, with a bullish technical signal from moving averages. The stock shows strong profitability with a 39% net income margin and a 6.6% dividend yield, though recent earnings have been mixed with two misses in the last four quarters. Cash flow improved in 2025 with net cash flow of $1.33 billion, but the balance sheet carries negative equity of -$2.24 billion due to high liabilities.

The outlook is balanced: analyst consensus is bullish with a $69.71 price target, but risks include regulatory pressures on tobacco, declining margins, and high debt. The dividend appears sustainable from cash flow, yet negative equity and business shrinkage pose long-term concerns for income-focused investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ENTG
34% Buy66% Sell
Avg holding period · 41 Days
MO
2% Buy98% Sell
Avg holding period · 154 Days

Top news

Latest headlines on both assets

About Entegris Inc

Entegris Inc is a supplier of advanced materials and process solutions for the semiconductor and other high-technology industries. The company's reportable segments include Specialty Chemicals & Engineered Materials (SCEM), Microcontamination Control (MC), and Advanced Materials Handling (AMH). The SCEM segment provides high-performance & high-purity process chemistries, gases, & materials, and safe & efficient delivery systems. The Microcontamination Control (MC) segment includes solutions to purify critical liquid chemistries and process gases used in semiconductor manufacturing processes and other high-technology industries. Its geographical segments are Taiwan, North America, South Korea, Japan, China, Europe, and Southeast Asia.

Read more on ENTG →

About Altria Group Inc

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).

Read more on MO →